Quantbot Technologies LP Has $653,000 Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Quantbot Technologies LP cut its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 32.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,357 shares of the company’s stock after selling 3,519 shares during the quarter. Quantbot Technologies LP’s holdings in U.S. Physical Therapy were worth $653,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. CBIZ Investment Advisory Services LLC raised its position in U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after acquiring an additional 122 shares in the last quarter. Venturi Wealth Management LLC raised its holdings in shares of U.S. Physical Therapy by 3,200.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares during the period. Pacer Advisors Inc. acquired a new stake in U.S. Physical Therapy in the 4th quarter valued at about $113,000. Mutual of America Capital Management LLC bought a new position in U.S. Physical Therapy during the fourth quarter worth about $203,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in U.S. Physical Therapy by 57.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock worth $223,000 after buying an additional 956 shares during the last quarter.

Insiders Place Their Bets

In other news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. This represents a 19.44 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Trading Down 0.1 %

Shares of U.S. Physical Therapy stock opened at $72.82 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a 50-day moving average of $83.58 and a 200-day moving average of $86.63. U.S. Physical Therapy, Inc. has a 52-week low of $72.15 and a 52-week high of $113.63. The stock has a market cap of $1.11 billion, a PE ratio of 77.47, a PEG ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. As a group, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a yield of 2.47%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s dividend payout ratio is currently 97.83%.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. JMP Securities assumed coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. StockNews.com downgraded shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday, February 28th. Barrington Research cut their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Finally, JPMorgan Chase & Co. decreased their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Wednesday, March 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.